Tcrx Therapeutics Co.ltd

This early-phase study is testing a new treatment called KXV01 for people with advanced solid tumors, including sarcomas, who have no other options. The therapy uses a patient's own immune cells, modified with a virus to recognize and attack their specific tumor. The main goal is…

This early-phase study tests a new drug called KSV01 in 18 adults with relapsed or refractory diffuse large B-cell lymphoma, a type of blood cancer that has not responded to standard treatments. The main goal is to check the safety of the injection and find the best dose. Partici…

This study collects peripheral blood mononuclear cells (immune cells) from 200 healthy volunteers aged 18 to 40 using a process called apheresis. The cells will be used in the lab to study how they grow and function, helping researchers develop new drugs. No treatment or medicati…